Monitor the company's ability to draw on the GHS equity line and the pace of share issuances, which will determine near-term dilution and cash runway. The ThermoLoop technology remains pre-commercial with no revenue timeline; watch for any prototype demonstration or licensing deal as the next potential catalyst.
Executive Summary
NewHydrogen filed an S-1 registration statement to register 275,000,000 shares of common stock for resale by GHS Investments, LLC, a financing partner under an equity financing agreement that could provide up to $3 million in gross proceeds. The company is a development-stage clean energy technology firm focused on a thermochemical green hydrogen production process (ThermoLoop) and has never generated revenue, with an accumulated deficit of $182.5 million and a going concern qualification from its auditors.
Key Facts
- S-1 registers 275,000,000 shares for resale by GHS Investments, LLC under an equity financing agreement dated September 8, 2026
- Company may receive up to $3,000,000 in gross proceeds from GHS; net proceeds estimated at ~$2.8 million
- Zero revenue generated since inception; accumulated deficit of $182,530,308 as of June 30, 2026
- Net loss of $1,740,818 for H1 2026 vs $1,099,798 for H1 2025 (loss widened 58%)
- Cash burn of $1,460,435 from operations in H1 2026; cash balance of $739,528 as of June 30, 2026
- Going concern qualification from auditor M&K CPAS, PLLC; management states cash sufficient for only ~2 months
- Outstanding options to purchase ~567.5 million shares at $0.0191 weighted average exercise price; Series C Preferred Stock convertible into ~2.46 billion common shares at $0.0014 per share
- Only 2 full-time employees; no independent directors; no audit committee
- Stock trades on OTCQB at $0.0156 per share as of September 17, 2026
- Officers and directors beneficially own ~42.5% of outstanding common stock
Financial Impact
Up to $3 million in potential gross proceeds from equity line; current cash burn rate of ~$2.9M/year implies less than 4 months of runway at current cash levels
Risk Factors
- Going concern risk: cash runway estimated at ~2 months from filing date based on H1 2026 burn rate
- Massive dilution: 567.5M options + 2.46B shares from preferred stock conversion + 275M shares registered here = potential dilution of over 4x current 819.7M outstanding shares
- No revenue and no path to commercialization disclosed; technology at early research stage with UC Santa Barbara
- Penny stock status and OTCQB listing limit institutional interest and liquidity
- Insider concentration (42.5% owned by 2 individuals) creates governance risk
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001493152-26-043738 |
| Exhibit: ex107.htm | 0001493152-26-043738 |
| Exhibit: ex5-1.htm | 0001493152-26-043738 |
| Exhibit: ex23-1.htm | 0001493152-26-043738 |
| Document: 0001493152-26-043738-index-headers.html | 0001493152-26-043738 |
| Document: 0001493152-26-043738-index.html | 0001493152-26-043738 |
| Document: 0001493152-26-043738.txt | 0001493152-26-043738 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $0.0185 | awaiting T+20 | — | $0.0245 (−32.43%) |
Oct 1, 2026 26d ago | EFFECT | $0.0161 | awaiting T+20 | — | $0.0245 (+52.17%) |
Sep 22, 2026 5w ago | S-1 | $0.0150 $0.0201 | ▼ −34.00% | ▼ −33.31% | $0.0245 (−63.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers